Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Aytu BioScience Inc. logo

Aytu BioScience Inc.

Sector: Healthcare   

Industry: Biotechnology

1.92
 
USD
  
0.27
  
(16.36%)
Optionable: Yes  Market Cap: 6 M  90-day average vol: 26,040

Previous close: 1.65  Open: 1.6752  Bid: 1.94  Ask: 2.0
52 week range    
1.38   
   4.88
Peers   
ROL / 
CGEM / 
NAUH / 
Last updated: Thursday 28th September 2023
59
MarketXLS Rank
40
Value
84
Technical
55
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

CGEM

1 B-8.914.06

LQDT

1 B13.115.46

NAUH

0 B1.50.0811

ROL

0.013115 B43.530.49
Financials

AYTU Income Statement

Annual
Aug-12Aug-13Jun-15Jun-16Jun-17Jun-18Jun-19Jun-20Jun-21Jun-22
Amortization90662.0664707.02 M2 M2 M4 M6 M4 M
Amortization of intangibles90662.0664707.02 M2 M2 M4 M6 M4 M
Basic EPS total-7.4-3.39
Basic weighted shares outstanding6 M5 M460395.087056.023301.0665605.0389724.02 M837333.029 M
Cost of sales-88109.0-957076.0-1 M-2 M-2 M8 M36 M-44 M
Depreciation-6150.0-58351.0-27000.0-51000.0-134000.0-294000.0-100000.0-100000.0-600000.0-2 M
Depreciation unreconciled90662.0664707.02 M2 M2 M4 M6 M4 M
DepreciationAndAmortization-6150.0-58351.090662.0664707.02 M2 M2 M4 M6 M4 M
Diluted EPS total-0.01-0.01-16.8-323.6-966.0-15.31-69.6-6.0-69.6-3.75
Diluted normalized net income/share-6.0-69.6
Diluted weighted shares outstanding6 M6 M459726.087083.023300.0665438.0389826.02 M837333.029 M
Earnings from equity interest212809.0
EarningsFromEquityInterestNetOfTax212809.0
Fees20000.020000.0400000.0
GainOnSaleOfBusiness-10 M
GainOnSaleOfPPE4 M80779.0-100000.0100000.0
GainOnSaleOfSecurity-21800.0-971629.0-61519.0-1 M-16000.02000.0
GeneralAndAdministrativeExpense50766.047984.0-51000.0-120000.0-139000.0-142000.0-100000.020 M26 M31 M
Gross operating profit1750.01750.0-137331.01 M-2 M-2 M5 M19 M29 M52 M
ImpairmentOfCapitalAssets8 M1 M2 M200000.013 M75 M
Income before tax-59675.0-57318.0-8 M-28 M-23 M-10 M-27 M-14 M-58 M-110 M
Income restructuring and M&A-6 M-6 M-2 M38 M700000.05 M
Income taxes300.0-23910.0-6000.0-100000.0-101000.0-192000.0-50000.0259000.0-110000.0
Interest income-10 M10 M4 M2 M
InterestExpenseNonOperating3319.04904.0114994.05 M3 M749423.0535500.03 M-6000.0-900000.0
InterestIncomeOperating-12572.0
MiscOtherSpecialCharges620325.0620325.03 M10 M7 M-3 M-4 M-693000.0
Net income from total operations-59675.0-57318.0-8 M-28 M-23 M-10 M-27 M-14 M-58 M-110 M
NetIncomeCommonStockholders-59675.0-57318.0-8 M-28 M-23 M-10 M-27 M-14 M-58 M-110 M
NetIncomeContinuousOperations-59675.0-57318.0-8 M-28 M-23 M-10 M-27 M-14 M-58 M-110 M
NetNonOperatingInterestIncomeExpense-3319.0-4904.0-114994.0-5 M-3 M-749423.0-10 M8 M4 M2 M
NetOperatingInterestIncomeExpense-114994.0
Operating income-56356.0-52414.0-8 M-14 M-22 M-22 M-17 M-18 M-38 M-36 M
Operating income before depreciation (EBITDA)-50206.0-47472.0-7 M-17 M-15 M-7 M-24 M-7 M-49 M-101 M
OperatingExpense58106.054164.0-8 M-24 M-23 M-23 M-24 M37 M67 M-164 M
Other income net21800.0-1 M971629.0-3 M-14 M-80779.0-5 M7 M693000.0
OtherGandA50766.047984.0-51000.0-120000.0-139000.0-142000.0-100000.020 M26 M31 M
OtherImpairmentOfCapitalAssets195278.0
OtherOperatingExpenses7340.06180.0203992.0191991.0387960.0-476000.0-1 M
PromotionAndAdvertising-1381.0-5 M-15 M-14 M
RentAndLandingFees30685.029904.0-51000.0-120000.0-139000.0-142000.0-100000.0-200000.031 M
Research & development expense3 M6 M959857.0167595.0589072.02 M6 M14 M
ResearchExpense3 M6 M959857.0167595.0589072.02 M6 M14 M
RestructringAndMnAIncome-6 M-6 M-2 M38 M700000.05 M
SalariesAndWages203992.0-903000.0-3 M-597000.0-1 M-1 M-4 M-5 M
Selling Gen & administrative expense50766.047984.04 M9 M17 M18 M19 M31 M56 M70 M
SellingAndMarketingExpense-1381.04 M9 M17 M18 M19 M11 M30 M39 M
SellingExpense4 M9 M17 M18 M19 M11 M30 M39 M
Special income/charges6 M-7 M-1 M-2 M-38 M-900000.0-18 M-75 M
Total Income available for interest expense (EBIT)-56356.0-52414.0-8 M-23 M-20 M-9 M-27 M-14 M-58 M-111 M
Total common shares outstanding5 M5 M50.050.050.02 M88440.0629186.01 M62 M
Total net income-59675.0-57318.0-8 M-28 M-23 M-10 M-27 M-14 M-58 M-110 M
Total ordinary shares4 M4 M4 M4 M4 M4 M4 M4 M4 M4 M
Total revenues1750.01750.0261782.03 M3 M4 M7 M28 M66 M97 M
TotalExpenses58106.054164.0-8 M-25 M-25 M-25 M-26 M46 M104 M-208 M
TotalRevenue1750.01750.0261782.03 M3 M4 M7 M28 M66 M97 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and Templates.
Get started today